1. Home
  2. MXC vs SKYE Comparison

MXC vs SKYE Comparison

Compare MXC & SKYE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

MXC

Mexco Energy Corporation

HOLD

Current Price

$9.45

Market Cap

17.6M

Sector

Energy

ML Signal

HOLD

Logo Skye Bioscience Inc.

SKYE

Skye Bioscience Inc.

HOLD

Current Price

$0.54

Market Cap

20.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MXC
SKYE
Founded
1972
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
17.6M
20.0M
IPO Year
1995
2013

Fundamental Metrics

Financial Performance
Metric
MXC
SKYE
Price
$9.45
$0.54
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$15.00
AVG Volume (30 Days)
10.5K
119.5K
Earning Date
02-10-2026
05-08-2026
Dividend Yield
1.02%
N/A
EPS Growth
N/A
N/A
EPS
0.24
N/A
Revenue
$2,705,235.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$39.35
N/A
Revenue Growth
7.12
N/A
52 Week Low
$7.16
$0.28
52 Week High
$16.48
$4.99

Technical Indicators

Market Signals
Indicator
MXC
SKYE
Relative Strength Index (RSI) 59.31 40.36
Support Level $8.65 $0.28
Resistance Level $9.59 $0.84
Average True Range (ATR) 0.45 0.06
MACD 0.05 0.00
Stochastic Oscillator 54.16 71.35

Price Performance

Historical Comparison
MXC
SKYE

About MXC Mexco Energy Corporation

Mexco Energy Corporation is an independent oil and gas company. It is engaged in the acquisition, exploration, development, and production of natural gas and crude oil properties located in the United States. The company carried out its operation in the Permian Basin of West Texas. It is focusing on two primary areas, the Delaware Basin located in the Western portion of the Permian Basin including Lea and Eddy Counties, New Mexico and Loving County, Texas, and the Midland Basin located in the Eastern portion of the Permian Basin including Reagan, Upton, Midland, Martin, Howard, and Glasscock Counties, Texas. The company generates revenue from Oil sales, Natural gas sales, oil and gas royalty interests.

About SKYE Skye Bioscience Inc.

Skye Bioscience Inc is a pre-clinical pharmaceutical company located in San Diego, California. The company's clinical assets focus on the modulation of cannabinoid receptor 1 ("CB1") to provide novel treatments and alternatives for diseases caused by metabolic disorders, inflammation, fibrosis, and neurodegeneration, such as obesity and glaucoma. The company's Phase 2 clinical candidates include nimacimab, a negative allosteric modulating antibody that inhibits peripheral CB1 receptors, currently being developed for the treatment of obesity and SBI-100 Ophthalmic Emulsion ("SBI-100 OE"), a CB1 agonist (activator), currently being developed for the treatment of glaucoma and ocular hypertension.

Share on Social Networks: